Compare TLX & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | BWIN |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.5B |
| IPO Year | 2024 | 2019 |
| Metric | TLX | BWIN |
|---|---|---|
| Price | $9.44 | $31.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | $20.54 | ★ $32.42 |
| AVG Volume (30 Days) | 353.8K | ★ 1.7M |
| Earning Date | 10-22-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,504,884,000.00 |
| Revenue This Year | $16.16 | $32.28 |
| Revenue Next Year | $13.08 | $10.67 |
| P/E Ratio | $150.33 | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $6.28 | $15.88 |
| 52 Week High | $13.11 | $32.71 |
| Indicator | TLX | BWIN |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 62.47 |
| Support Level | $8.69 | $31.70 |
| Resistance Level | $9.70 | $32.58 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 32.62 | 100.00 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.